Understanding the role of biofilms in acute recurrent tonsillitis through 3D bioprinting of a novel gelatin-PEGDA hydrogel

Denton, O., Wan, Y., Beattie, L., Jack, T., McGoldrick, P., McAllister, H., Mullan, C., Douglas, C. M. and Shu, W. (2024) Understanding the role of biofilms in acute recurrent tonsillitis through 3D bioprinting of a novel gelatin-PEGDA hydrogel. Bioengineering, 11(3), 202. (doi: 10.3390/bioengineering11030202) (PMID:38534476) (PMCID:PMC10967717)

[img] Text
323904.pdf - Published Version
Available under License Creative Commons Attribution.

8MB

Abstract

Acute recurrent tonsillitis is a chronic, biofilm-related infection that is a significant burden to patients and healthcare systems. It is often treated with repeated courses of antibiotics, which contributes to antimicrobial resistance. Studying biofilms is key to understanding this disease. In vitro modelling using 3D bioprinted hydrogels is a promising approach to achieve this. A novel gelatin-PEGDA pseudomonas fluorescens-laden bioink was developed and bioprinted in a 3D hydrogel construct fabricated using computer-aided design to mimic the tonsillar biofilm environment. The bioprinted constructs were cultured at 37 °C in lysogeny broth for 12 days. Bacterial growth was assessed by spectrophotometry. Cellular viability analysis was conducted using optical fluorescence microscopy (FDA/PI staining). A biocompatible 3D-printed bacteria-laden hydrogel construct was successfully fabricated. Bacterial growth was observed using optical fluorescence microscopy. A live/dead cellular-staining protocol demonstrated bacterial viability. Results obtained after the 12-day culture period showed higher bacterial growth in the 1% gelatin concentration construct compared to the 0% control. This study demonstrates the first use of a bacteria-laden gelatin-PEGDA hydrogel for biofabrication of a 3D-printed construct designed to model acute recurrent tonsillitis. Initiating a study with clinically relevant ex vivo tonsil bacteria will be an important next step in improving treatment of this impactful but understudied disease.

Item Type:Articles
Additional Information:We acknowledge the funding support of the Medical Research Council (MRC) CARP award (MR/W030381/1) and EPSRC (EP/W004860/1, EP/X033686/1). This research was also partially funded by Glasgow Children’s Hospital Charity, Academic activities of CD are supported by a Chief Scientist Office NRS Fellowship and MRC (MR/W030381/1).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Denton, Dr Oliver and Douglas, Miss Catriona
Creator Roles:
Denton, O.Conceptualization, Methodology, Investigation, Writing – original draft, Writing – review and editing, Visualization
Douglas, C.Methodology, Resources, Writing – review and editing, Supervision, Project administration, Funding acquisition
Douglas, C. M.Conceptualization
Authors: Denton, O., Wan, Y., Beattie, L., Jack, T., McGoldrick, P., McAllister, H., Mullan, C., Douglas, C. M., and Shu, W.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Bioengineering
Publisher:MDPI
ISSN:2306-5354
ISSN (Online):2306-5354
Published Online:21 February 2024
Copyright Holders:Copyright © 2024 by the authors
First Published:First published in Bioengineering 11(3):202
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record